AMY STAFFORD: Open Payments
NPI 1386845964 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$726 in 25 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $836 · 2025 $726
Food & beverage: $527Education: $199
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $333 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Actelion Pharmaceuticals US, Inc. | 1 | $99 |
| Galderma Laboratories, L.P. | 4 | $79 |
| ABBVIE INC. | 4 | $69 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $19 |
| Organon LLC | 1 | $7 |
Products named: DUPIXENT, OPSUMIT, NEMLUVIO, SKYRIZI, SPEVIGO, OTEZLA, VTAMA.
Industry payments across LA — which companies pay providers there.
